VKTX Pulls Back
Following its recent surge on weight-loss drug data, the stock is falling violently as investors lock in profits.
Sources: https://www.theglobeandmail.com/investing/markets/stocks/LLY/pressreleases/4890583/viking-therapeutics-stock-soars-36-on-weight-loss-drug-data-why-its-not-too-late-to-buy-the-stock/, https://www.businesswire.com/news/home/20261001749138
Ezbrisk weighs each event against the market reaction and publishes a verdict with an overreaction reading. How the methodology works